Fertility-sparing treatment for patients with endometrial carcinoma.

T Ind
Author Information

Abstract

No abstract text available.

References

  1. Hum Reprod Open. 2023 Feb 06;2023(1):hoac057 [PMID: 36756380]
  2. Facts Views Vis Obgyn. 2023 Mar;15(1):3-23 [PMID: 37010330]
  3. Int J Gynecol Cancer. 2023 Feb 6;33(2):208-222 [PMID: 36746507]
  4. Virchows Arch. 2021 Feb;478(2):153-190 [PMID: 33604759]
  5. J Natl Compr Canc Netw. 2021 Aug 01;19(8):888-895 [PMID: 34416706]
  6. Virchows Arch. 2018 Jun;472(6):919-936 [PMID: 29725757]
  7. Best Pract Res Clin Obstet Gynaecol. 2021 Sep;75:1 [PMID: 34412772]
  8. Int J Gynecol Cancer. 2018 May;28(4):641-655 [PMID: 29688967]
  9. Eur J Obstet Gynecol Reprod Biol. 2021 Jan;256:433-465 [PMID: 33143928]
  10. Radiother Oncol. 2021 Jan;154:327-353 [PMID: 33712263]
  11. Radiother Oncol. 2018 Jun;127(3):404-416 [PMID: 29728273]
  12. Int J Gynecol Cancer. 2021 Jan;31(1):12-39 [PMID: 33397713]
  13. Eur J Obstet Gynecol Reprod Biol. 2022 Mar;270:50-89 [PMID: 35065448]

Word Cloud

Created with Highcharts 10.0.0Fertility-sparingtreatmentpatientsendometrialcarcinoma

Similar Articles

Cited By